Immune activation or immunomodulation in the brains of MPS IIIB mice? Commentary on "Innate and adaptive immune activation in the brain of MPS IIIB mouse model".
Archer
Louise D
LD
The Transplant Centre, University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom.
Langford
Kia
K
Bigger
Brian
B
Fildes
James E
JE
D000818:Animals; D015703:Antigens, CD / Q000378:metabolism; D001323:Autoantibodies / Q000378:metabolism; D035843:Biomedical Research / Q000379:methods; D001921:Brain / Q000276:immunology* / Q000502:physiology*; D060908:CTLA-4 Antigen; D005260:Female; D008297:Male; D051379:Mice; D008954:Models, Biological; D015213:Neuroimmunomodulation / Q000502:physiology*; D051918:Sialic Acid Binding Ig-like Lectin 2 / Q000378:metabolism; D013154:Spleen / Q000276:immunology / Q000502:physiology; D013601:T-Lymphocytes / Q000276:immunology / Q000502:physiology; D051195:Toll-Like Receptor 2 / Q000378:metabolism; D051216:Toll-Like Receptor 6 / Q000378:metabolism; D015854:Up-Regulation / Q000276:immunology / Q000502:physiology
D015703:Antigens, CD; D001323:Autoantibodies; D060908:CTLA-4 Antigen; C497868:Cd22 protein, mouse; C556707:Ctla4 protein, mouse; D051918:Sialic Acid Binding Ig-like Lectin 2; C493486:Tlr2 protein, mouse; C495369:Tlr6 protein, mouse; D051195:Toll-Like Receptor 2; D051216:Toll-Like Receptor 6